Management of Pulmonary Arterial Hypertension With a Focus on Combination Therapies
- 31 May 2007
- journal article
- review article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 26 (5) , 437-446
- https://doi.org/10.1016/j.healun.2007.01.035
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Efficacy and Safety of Sildenafil Added to Treprostinil in Pulmonary HypertensionThe American Journal of Cardiology, 2005
- Goal-oriented treatment and combination therapy for pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- Effects of Long-Term Bosentan in Children With Pulmonary Arterial HypertensionJournal of the American College of Cardiology, 2005
- Ambrisentan Therapy for Pulmonary Arterial HypertensionPublished by Elsevier ,2005
- Combination therapy with bosentan and phosphodiesterase-5 inhibitor in pulmonary arterial hypertensionEuropean Respiratory Journal, 2005
- Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial HypertensionCirculation, 2005
- Treatment of Pulmonary Arterial HypertensionNew England Journal of Medicine, 2004
- Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentanThe American Journal of Cardiology, 2004
- The use of bosentan and a prostacyclin analog in the treatment of primary pulmonary hypertensionThe Journal of Heart and Lung Transplantation, 2003
- Survival in Primary Pulmonary HypertensionCirculation, 2002